Publication | Open Access

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

UrologyMetastatic Urothelial CarcinomaGenitourinary CancerMedicinePharmacologyPharmacotherapyProstatic DiseaseOncologyAron-2 Retrospective Study